Clinical Thyroidology for the Public Volume 10
Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association®.
Search Clinical Thyroidology for the Public
-
In this issue Volume 10 Issue 7, the studies ask the following questions:
- Does bariatric surgery change levothyroxine requirements among hypothyroid patients?
- How can treatment of hypothyroidism in older patients be improved?
- How often do patients require thyroid hormone therapy after lobectomy?
- What is the role of thyroglobulin testing and neck ultrasound in determining the need for radioactive iodine therapy?
- Does low-dose vs high-dose radioactive iodine therapy change recurrence rates in thyroid cancer?
- What is the role of surgery in thyroid cancer recurrence?
-
In this issue Volume 10 Issue 6, the studies ask the following questions:
- Do all patients with thyroid cancer require surgery?
- Should 45 years of age still be a cutoff to determine more aggressive thyroid cancer?
- What is the thyroid cancer risk in adults after radiation exposure as a child?
- Does getting thyroid cancer as a child affect long term quality of life?
- Why do some patients with low risk thyroid cancer have aggressive disease?
-
In this issue Volume 10 Issue 5, the studies ask the following questions:
- What do the new American Thyroid Association Thyroid Disease in Pregnancy and the Postpartum guidelines mean for patients?
- Should subclinical hypothyroidism during pregnancy be treated?
- Does pregnancy affect the progression of thyroid cancer?
- Can a new clinical scoring system predict the outcome of antithyroid treatment in Graves’ disease?
- What is the efficacy and safety of the three treatment options for Graves’ disease?
- What are the treatment options for anaplastic thyroid cancer?
-
In this issue Volume 10 Issue 4, the studies ask the following questions:
- What are the risk factors for death in patients with myxedema coma?
- Does hyperthyroidism increase the risk of heart problems and death?
- Do thyroid nodules change in size during pregnancy?
- Is ultrasound useful to identify abnormal lymph nodes prior to surgery for thyroid cancer?
- Is the diffuse sclerosing variant of papillary thyroid cancer more aggressive?
- How often is medullary thyroid cancer found in both thyroid lobes in people without hereditary medullary thyroid cancer?
-
In this issue Volume 10 Issue 3, the studies ask the following questions:
- Does air pollution affect the baby’s thyroid function during pregnancy?
- Are high TSH levels a risk factor for death from all causes?
- Are high FT4 levels a risk factor for sudden cardiac death?
- Are high FT4 levels a risk factor for cancer?
- Can we predict which Graves disease patients will relapse after antithyroid drugs are stopped?
-
In this issue Volume 10 Issue 2, the studies ask the following questions:
- Is subclinical thyroid disease associated with early dementia?
- Should patient age and gender influence screening for hypothyroidism?
- How often is iodine supplementation recommended to pregnant women?
- Is the incidence of thyroid cancer actually increasing all over the world?
- Do screening programs lead to an over-diagnosis of thyroid cancer?
- Do thyroid cancers differ depending on which gene mutations are associated with the cancer?
-
In this issue Volume 10 Issue 1, the studies ask the following questions:
- Does a normal TSH mean that patients are on the right levothyroxine dose?
- Is there an association between thyroid problems and gestational diabetes?
- Can less aggressive thyroid cancers be diagnosed by thyroid biopsy cytology?
- How well does molecular marker analysis identify benign indeterminate nodules?
- Does dividing small thyroid cancers into two separate groups affect prognosis?
- Does the timing of radioactive iodine therapy after thyroidectomy affect
prognosis?
Clinical Thyroidology for the Public Past Issues
2014 – 2016
2011 – 2013
2008 – 2010
Editor
Alan P. Farwell, MD, FACE
Editorial Board
Jessie Block-Galaraza, MD, Albany, NY
Gary Bloom, New York, NY
Alina Gavrile-Filip, MD, Boston, MA
Melanie Goldfarb, MD, MS, FACS, FACE, Santa Monica, CA
Shirin Haddady, MD, MPH, Boston, MA
Julie E. Hallanger Johnson, MD, Tampa, FL
Ronald Kuppersmith, MD, College Station, TX
Angela Leung, MD, Los Angeles, CA
Maria Papaleontiou, MD, Ann Arbor, MI
Liuska Pesce, MD, Iowa City, Iowa
Wendy Sacks, MD, Los Angeles, CA
Anna M. Sawka, MD, Toronto, ON, Canada
Phillip Segal, MD, Toronto, ON, Canada
Vibhavsu Sharma, MD, Albany, NY
Whitney Woodmansee, MD, Jacksonville, FL
